JAN 12, 2021 10:58 AM PST

SGLT2 Inhibitors Can Reduce the Cardiovascular Risk for Diabetics Being Treated with Insulin

WRITTEN BY: Jasper Cantrell

One of the biggest problems that come alongside diabetes is the increased risk of cardiovascular disease. Treatment of diabetes often reduces the risk, but some scientists wonder if the treatments reduce the risk by treating diabetes or directly affecting the cardiovascular system.

One of the go-to treatments for type 2 diabetes is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. This protein is a regulator of sugar in the blood, and its inhibition can increase the amount of sugar excreted by the bladder. Dapagliflozin, empagliflozin, and canagliflozin are all drugs that use this mechanism to control sugar levels in diabetic patients. Still, some recent evidence suggests these may also independently reduce the risk of cardiovascular disease.

In a new study, a team from the University Medical Center Hamburg-Eppendorf in Germany wanted to investigate further. A few recent studies have shown that SGLT2 inhibitors lowered the risk of cardiovascular hospitalization or death in patients with diabetes. However, these studies were conducted in the absence of insulin, a common diabetes treatment. This new study investigated whether the reduced cardiovascular risk could also be seen in patients treated with insulin.

To do this, the team examined the cardiovascular biomarkers hematocrit, red blood cell count, and reticulocyte in a double-blind, randomized trial. All are indicators of cardiovascular risk. Enrolled patients were being treated with insulin and were put in either a placebo group or given a certain dose of the SGLT2 inhibitor dapagliflozin.

The study found that dapagliflozin treatment increased both hematocrit levels in the blood and red blood cell count across the 104-week trial. Reticulocytes, a precursor to red blood cells, increased during the first 4-weeks but then dropped back down to levels akin to the placebo group. These results suggest that SGLT2 inhibitors have the same effect against cardiovascular risk in diabetic patients treated with insulin as they do with patients not being treated with insulin.

This study followed markers of cardiovascular risk during dapagliflozin treatment in a group of diabetic patients already being treated with insulin. They did not independently measure the onset of cardiovascular disease in their study, however previous studies had found that the increases to hematocrit, red blood cell count, and reticulocytes correlate well with a reduced cardiovascular risk in diabetic patients.  

The study concludes, “In summary, we show that dapagliflozin induces a long-term and dose-dependent elevation in haematocrit that is preserved in patients receiving concomitant insulin treatment, including chronic insulin therapy.”

Sources: Nature Scientific Reports, AJMCtv

About the Author
Bachelors of the Sciences
Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
JUN 12, 2022
Plants & Animals
Vegan Diet Rich in Legumes Helps with Weight Loss
JUN 12, 2022
Vegan Diet Rich in Legumes Helps with Weight Loss
New research conducted by the Physicians Committee for Responsible Medicine suggests that a vegan diet offers a range of ...
JUN 21, 2022
Cardiology
Sudden Cardiac Death and Genetics in Athletes
JUN 21, 2022
Sudden Cardiac Death and Genetics in Athletes
A new publication outlines recommendations for genetic testing in athletes.
JUL 13, 2022
Cardiology
Eating Eggs May Lower Heart Disease Risk
JUL 13, 2022
Eating Eggs May Lower Heart Disease Risk
Eating up to one egg per day may lower heart disease risk.
JUL 20, 2022
Cardiology
Light Exposure During Sleep Linked to Obesity, Hypertension in Older Adults
JUL 20, 2022
Light Exposure During Sleep Linked to Obesity, Hypertension in Older Adults
Keeping your bedroom dark at night could have a major impact on your health.
SEP 29, 2022
Cardiology
Hypertension in Children, Teens Linked to Unhealthy Lifestyle
SEP 29, 2022
Hypertension in Children, Teens Linked to Unhealthy Lifestyle
Inactivity, sugar, salt, and weight gain are causing hypertension in children and teens.
NOV 22, 2022
Plants & Animals
Honey Helps Improve Cardiometabolic Health
NOV 22, 2022
Honey Helps Improve Cardiometabolic Health
Honey has long been explored as an alternative to regular sugar in our diets. In fact, some nutritionists even prioritiz ...
Loading Comments...